Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients

Summary

The purpose of this study is to assessed the efficacy of a combined solution of ethanol (4%) and low molecular weight heparins LMWH in preventing tunnelled dialysis catheter infection in chronic hemodialysis patients

Conditions

• Tunnelled Hemodialysis Catheter Infection

Interventions

DRUG

Ethanol

An ethanol 40 % v/v - enoxaparin 1000 U/mL (Ethenox) interdialytic lock solution

DRUG

enoxaparin

An ethanol 40 % v/v - enoxaparin 1000 U/mL (Ethenox) interdialytic lock solution

Sponsors & Collaborators

• Ministry of Health, France

  collaborator OTHER_GOV

• CH du Puy en Velay, Hôpital Emile Roux

  collaborator UNKNOWN

• University Hospital, Toulouse

  collaborator OTHER

• Centre hospitalier de Chambéry

  collaborator UNKNOWN

• Calydial

  collaborator OTHER

• Hôpital Edouard Herriot

  collaborator OTHER

• Nouvel Hôpital Civil, 1 place de l'Hôpital 67091 Strasbourg cedex

  collaborator UNKNOWN

• Hôpital Lapeyronie

  collaborator UNKNOWN

• Centre de dialyse d'Alès

  collaborator UNKNOWN

• University Hospital of Saint-Etienne

  collaborator OTHER

• Centre hospitalier de Perpignan

  collaborator OTHER

• Centre de néphrologie Polyclinique Médipôle Saint-Roch, Rue Ambroise Croizat

  collaborator UNKNOWN

• CHU Hôpital Maison Blanche, 45 Rue Cognacq-Jay 51092 REIMS Cedex

  collaborator UNKNOWN

• University Hospital, Clermont-Ferrand

  lead OTHER

Principal Investigators

• Julien ANIORT · University Hospital, Clermont-Ferrand

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2018-02-09

Primary Completion

2026-12-31

Completion

2027-12-31

Countries

• France

Study Locations